Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

SHOP APOTHEKE EUROPE N.V., NL0012044747

SHOP APOTHEKE EUROPE N.V., NL0012044747

21.04.2021 - 19:32:01

SHOP APOTHEKE EUROPE N.V.: Annual General Meeting approves all items on the agenda and appoints Henriette Peucker as a member of the Supervisory Board.

?

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of Europe's leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Warsaw, Milan, Paris and Tongeren, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 6.8 million active customers trust SHOP APOTHEKE EUROPE.

Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services.

In preparation for the introduction of electronic prescriptions in Germany in summer 2021, the company will further improve the customer experience with focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer into a truly customer-centric e-pharmacy platform.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and has been part of the MDAX stock index since September 2020. ?

PRESS CONTACTS.

Trade and popular media: Sven Schirmer Tel: +49 221 99 53 44 31 Email: presse@shop-apotheke.com

Financial media: Bettina Fries Tel: +49 211 75 80 779 Email: presse@shop-apotheke.com

Investor relations: Carmen Herkenrath Tel.: +31 77 850 6109 Email:?carmen.herkenrath@shop-apotheke.com

Thomas Schnorrenberg Mobile: +49 151 465 31317 Email:?presse@shop-apotheke.com

21.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: SHOP APOTHEKE EUROPE N.V. Dirk Hartogweg 14 5928 LV Venlo

Netherlands Phone: 0800 - 200 800 300 Fax: 0800 - 90 70 90 20 E-mail: carmen.herkenrath@shop-apotheke.com Internet: www.shop-apotheke-europe.com ISIN: NL0012044747, DE000A19Y072 WKN: A2AR94, A19Y07 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1187389 ? End of News DGAP News Service

1187389??21.04.2021?

@ dgap.de